Davis's Drug Guide
maralixibat
General
Genetic Implications:
Pronunciation:
mar-a-lix--i-bat
Trade Name(s)
- Livmarli
Ther. Class.
none assigned
Pharm. Class.
temporary class
ileal bile acid transporterThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Maralixibat." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580060/all/maralixibat.
Vallerand AHA, Sanoski CAC, . Maralixibat. Davis's Drug Guide. F.A. Davis Company; 2025. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580060/all/maralixibat. Accessed April 15, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Maralixibat. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580060/all/maralixibat
Vallerand AHA, Sanoski CAC, . Maralixibat [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 15]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580060/all/maralixibat.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - maralixibat
ID - 3580060
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580060/all/maralixibat
PB - F.A. Davis Company
ET - 19
DB - Nursing Central
DP - Unbound Medicine
ER -
